-
Product Insights
NewLikelihood of Approval Analysis for Polycystic Kidney Disease
Overview How likely is it that the drugs in Polycystic Kidney Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Polycystic Kidney Disease Overview Polycystic kidney disease (PKD) is a disorder...
-
Product Insights
NewLikelihood of Approval Analysis for Kidney Transplant Rejection
Overview How likely is it that the drugs in Kidney Transplant Rejection will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Kidney Transplant Rejection Overview Kidney transplantation is a therapy performed to...
-
Product Insights
NewLikelihood of Approval Analysis for Chronic Kidney Disease (Chronic Renal Failure)
Overview How likely is it that the drugs in Chronic Kidney Disease (Chronic Renal Failure) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Chronic Kidney Disease (Chronic Renal Failure) Overview Chronic...
-
Product Insights
NewLikelihood of Approval Analysis for Anemia in Chronic Kidney Disease (Renal Anemia)
Overview How likely is it that the drugs in Anemia in Chronic Kidney Disease (Renal Anemia) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anemia in Chronic Kidney Disease (Renal Anemia)...
-
Product Insights
NewLikelihood of Approval Analysis for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
Overview How likely is it that the drugs in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. End-Stage Kidney Disease (End-Stage Renal Disease...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tegoprubart in Kidney Transplant Rejection
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tegoprubart in Kidney Transplant Rejection report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tegoprubart in Kidney Transplant Rejection Drug Details: Tegoprubart is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zanubrutinib in Kidney Disease (Nephropathy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zanubrutinib in Kidney Disease (Nephropathy) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zanubrutinib in Kidney Disease (Nephropathy) Drug Details: Zanubrutinib (Brukinsa) acts...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sizavaleucel in Kidney Transplant Rejection
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sizavaleucel in Kidney Transplant Rejection report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sizavaleucel in Kidney Transplant Rejection Drug Details: MDR-101 is under development...
-
Product Insights
NewPolycystic Kidney Disease Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Polycystic Kidney Disease Clinical Trial Report Overview A total of 238 polycystic kidney disease clinical trials were conducted as of March 2024. The polycystic kidney disease clinical trial report provides a comprehensive understanding of the polycystic kidney disease clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor types and the prominent sponsors associated with the trials. Key Regions...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – VB-119 in Kidney Disease (Nephropathy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VB-119 in Kidney Disease (Nephropathy) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VB-119 in Kidney Disease (Nephropathy) Drug Details: VB-119 is under development for...